Real-world effectiveness and safety of insulin glargine 300 U/ml in insulin-naïve people with type 2 diabetes in the Latin America region: A subgroup analysis of the ATOS.
Hernando Vargas-UricoecheaJosé Luis Burga NuñezJuan Rosas GuzmánLiliana Silva-GomezSergio BeltranMaría Elena Sañudo-MauryPublished in: Diabetes, obesity & metabolism (2022)
In a real-world setting in the Latin America region, the initiation of Gla-300 in people with T2D uncontrolled on OADs resulted in improved glycaemic control with a low incidence of hypoglycaemia and no change in body weight.